Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania.
about
WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective studyEstimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study.Modelling the potential population impact and cost-effectiveness of self-testing for HIV: evaluation of data requirements.Brucellosis among hospitalized febrile patients in northern TanzaniaLow prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.Who tests, who doesn't, and why? Uptake of mobile HIV counseling and testing in the Kilimanjaro Region of Tanzania.Photographed rapid HIV test results pilot novel quality assessment and training schemes.Low specificity of determine HIV1/2 RDT using whole blood in south west Tanzania.PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region.Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort studyInvasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania.Leptospirosis among hospitalized febrile patients in northern TanzaniaQ fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania.Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern TanzaniaInvasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern TanzaniaChikungunya and dengue fever among hospitalized febrile patients in northern TanzaniaHigh accuracy of home-based community rapid HIV testing in rural MalawiPerformance of nucleic acid amplification following extraction of 5 milliliters of whole blood for diagnosis of Mycobacterium tuberculosis bacteremia.Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women.Economic evaluations in gastroenterology in Brazil: A systematic review.Would you test for 5000 Shillings? HIV risk and willingness to accept HIV testing in Tanzania.Changes in HIV risk behavior and seroincidence among clients presenting for repeat HIV counseling and testing in Moshi, Tanzania.Establishment of biochemistry reference values for healthy Tanzanian infants, children and adolescents in Kilimanjaro RegionUtility of rapid antibody tests to exclude HIV-1 infection among infants and children aged <18 months in a low-resource setting.Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study.Predicting mortality for paediatric inpatients where malaria is uncommonThe cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting.Blood glucose as a predictor of mortality in children admitted to the hospital with febrile illness in TanzaniaLeptospirosis and human immunodeficiency virus co-infection among febrile inpatients in northern Tanzania.Chest radiography for predicting the cause of febrile illness among inpatients in Moshi, Tanzania.Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.Experience of offering HIV rapid testing to at-risk patients in community health centers in eight Chinese cities.Severe febrile illness in adult hospital admissions in Tanzania: a prospective study in an area of high malaria transmission.Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon.Measures and Metrics for Feasibility of Proof-of-Concept Studies With Human Immunodeficiency Virus Rapid Point-of-Care Technologies: The Evidence and the Framework.
P2860
Q28748256-313C505F-2028-40FB-887B-4A49DD721969Q30394281-676BB009-0FD5-4FCF-8531-28A4EDABE6CEQ30832974-2E6D54CE-F957-4C45-A459-C6FC37E16753Q33403969-93A290A2-1703-4038-BC3C-1B13E400FEF6Q33769510-FD5BE9AD-6489-4DB8-8D77-235E05BE44EAQ33815661-D1736C88-B997-406B-80ED-9B64D6F03A19Q33869804-07F51E3A-0D49-498A-BE1D-C22CC95E4CFBQ34328165-69D6B200-5C22-492A-943A-065AF349BCD6Q34351507-7ADA698E-5252-43AF-83D2-7CE85FFBE0C8Q34507631-EA95407A-45E0-492B-B2C7-BFBA219042EEQ34855404-5190FBF8-5116-4207-9519-F8DB34C3AB3DQ35019855-3503D930-F0BD-4026-BA2A-FD8B99C5F5A5Q35063882-1781382D-E8A5-43AE-B6FF-9B2E56081E3CQ35131397-331ABB0E-9023-4B00-A2D8-05D44C420E91Q35141256-9FCBB555-386F-4019-8C1B-4A0E223D17E1Q35152538-B829362F-1995-4168-AF4F-D2C12F48B014Q35583353-0FFDAFCB-2D08-4F34-A7C0-3C0FD297B60FQ35637100-40A1AD73-1342-4603-A94D-C30F66FE10CCQ35642985-2B40835F-922F-4903-9B85-E75289AF6CFBQ35668208-AF1D41EF-E109-470F-87A1-ED2B26301EB4Q35685061-D266BB87-72F7-48FB-8594-857E1685019AQ35917406-3620FE61-E9A5-4CCE-BB94-545BA3B1B3D2Q35967841-E76A300F-9487-43B8-9D19-4C5BD208B346Q36089732-306E6C0A-1312-4B24-AFD1-8347E908E502Q36122583-B530E417-FAE4-40B5-BB37-F60956E8C212Q36254105-A32CD17D-C13E-4BEA-B23F-A903026477A6Q36379384-09323D5C-B41B-4976-BB5C-09A4F709C83FQ36430115-35408406-BF11-4CFA-949D-54A853678DF6Q36843894-6CEE6F94-7E55-4D04-91AE-B242E3A95067Q37089574-CF588757-9555-42FE-9D24-CA9D7681475EQ37089900-6AA12768-BD96-466F-AAD4-712ABBD60B35Q37138461-552FAAE6-C7FC-492F-84A6-8460C1AED76DQ37386429-C093B078-BA52-4137-8E61-576BF481BD67Q37525384-48C627E9-941C-469D-A9FC-45817AFA2CEFQ38047599-92ED468A-FCC4-43D7-9C24-B16DEB11582FQ45374189-AEE2F1BB-B497-40EF-9685-BDC426216651Q47553793-911EF186-4B2E-4AAF-BA49-C9CD9AC33580
P2860
Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Validation, performance under ...... esting algorithms in Tanzania.
@en
type
label
Validation, performance under ...... esting algorithms in Tanzania.
@en
prefLabel
Validation, performance under ...... esting algorithms in Tanzania.
@en
P2093
P2860
P356
P1476
Validation, performance under ...... esting algorithms in Tanzania.
@en
P2093
Anne B Morrissey
Brian Wells Pence
Christopher O Odhiambo
Epimack Ndanu
Isaac A Afwamba
John F Shao
Meghan K Mayhood
Nathan M Thielman
P2860
P304
P356
10.1128/JCM.01045-08
P407
P50
P577
2008-10-15T00:00:00Z